{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T11:37:58Z","timestamp":1794915478843,"version":"4.9.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-022-03137-0","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T04:03:05Z","timestamp":1644552185000},"page":"2355-2364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein (HDL) ratio (MHR) in chronic kidney disease patients"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4396-5032","authenticated-orcid":false,"given":"Valeria","family":"Cernaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Loddo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Corsaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Macaione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina Teresa","family":"Ferlazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia Maria","family":"Cigala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Crea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"De Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Gembillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Longhitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Buemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Benvenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"issue":"23","key":"3137_CR1","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1042\/cs20160393","volume":"130","author":"S Liabeuf","year":"2016","unstructured":"Liabeuf S, Villain C, Massy ZA (2016) Protein-bound toxins: has the Cinderella of uraemic toxins turned into a princess? Clin Sci 130(23):2209\u20132216. https:\/\/doi.org\/10.1042\/cs20160393","journal-title":"Clin Sci"},{"issue":"5","key":"3137_CR2","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3109\/0886022x.2015.1015683","volume":"37","author":"V Cernaro","year":"2015","unstructured":"Cernaro V, Medici MA, Leonello G, Buemi A, Kohnke FH, Villari A, Santoro D, Buemi M (2015) Auxin induces cell proliferation in an experimental model of mammalian renal tubular epithelial cells. Ren Fail 37(5):911\u2013913. https:\/\/doi.org\/10.3109\/0886022x.2015.1015683","journal-title":"Ren Fail"},{"key":"3137_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-020-02469-z","author":"V Cernaro","year":"2020","unstructured":"Cernaro V, Loddo S, Macaione V, Ferlazzo VT, Cigala RM, Crea F, De Stefano C, Genovese ARR, Gembillo G, Bolignano D, Santoro D, Vita R, Buemi M, Benvenga S (2020) RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus. Int Urol Nephrol. https:\/\/doi.org\/10.1007\/s11255-020-02469-z","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"3137_CR4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/ki.2013.133","volume":"84","author":"B Gondouin","year":"2013","unstructured":"Gondouin B, Cerini C, Dou L, Sall\u00e9e M, Duval-Sabatier A, Pletinck A, Calaf R, Lacroix R, Jourde-Chiche N, Poitevin S, Arnaud L, Vanholder R, Brunet P, Dignat-George F, Burtey S (2013) Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway. Kidney Int 84(4):733\u2013744. https:\/\/doi.org\/10.1038\/ki.2013.133","journal-title":"Kidney Int"},{"issue":"4","key":"3137_CR5","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1681\/asn.2013121283","volume":"26","author":"L Dou","year":"2015","unstructured":"Dou L, Sall\u00e9e M, Cerini C, Poitevin S, Gondouin B, Jourde-Chiche N, Fallague K, Brunet P, Calaf R, Dussol B, Mallet B, Dignat-George F, Burtey S (2015) The cardiovascular effect of the uremic solute indole-3 acetic acid. J Am Soc Nephrol 26(4):876\u2013887. https:\/\/doi.org\/10.1681\/asn.2013121283","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"3137_CR6","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1046\/j.1523-1755.2003.00906.x","volume":"63","author":"M Motojima","year":"2003","unstructured":"Motojima M, Hosokawa A, Yamato H, Muraki T, Yoshioka T (2003) Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-kappaB and free radical in proximal tubular cells. Kidney Int 63(5):1671\u20131680. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00906.x","journal-title":"Kidney Int"},{"issue":"3","key":"3137_CR7","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1159\/000074327","volume":"95","author":"M Satoh","year":"2003","unstructured":"Satoh M, Hayashi H, Watanabe M, Ueda K, Yamato H, Yoshioka T, Motojima M (2003) Uremic toxins overload accelerates renal damage in a rat model of chronic renal failure. Nephron Exp Nephrol 95(3):e111-118. https:\/\/doi.org\/10.1159\/000074327","journal-title":"Nephron Exp Nephrol"},{"key":"3137_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041522","author":"J Paats","year":"2020","unstructured":"Paats J, Adoberg A, Arund J, Dhondt A, Fernstr\u00f6m A, Fridolin I, Glorieux G, Leis L, Luman M, Gonzalez-Parra E, Perez-Gomez VM, Pilt K, Sanchez-Ospina D, Segelmark M, Uhlin F, Arduan Ortiz A (2020) Serum levels and removal by haemodialysis and haemodiafiltration of tryptophan-derived uremic toxins in ESKD patients. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21041522","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3137_CR9","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/ndt\/gfv038","volume":"30","author":"T Cornelis","year":"2015","unstructured":"Cornelis T, Eloot S, Vanholder R, Glorieux G, van der Sande FM, Scheijen JL, Leunissen KM, Kooman JP, Schalkwijk CG (2015) Protein-bound uraemic toxins, dicarbonyl stress and advanced glycation end products in conventional and extended haemodialysis and haemodiafiltration. Nephrol Dial Transplant 30(8):1395\u20131402. https:\/\/doi.org\/10.1093\/ndt\/gfv038","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"3137_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.repc.2017.06.021","volume":"37","author":"A Sercelik","year":"2018","unstructured":"Sercelik A, Besnili AF (2018) Increased monocyte to high-density lipoprotein cholesterol ratio is associated with TIMI risk score in patients with ST-segment. Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia = Portuguese J Cardiol Off J Portuguese Soc Cardiol 37(3):217\u2013223. https:\/\/doi.org\/10.1016\/j.repc.2017.06.021","journal-title":"Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia = Portuguese J Cardiol Off J Portuguese Soc Cardiol"},{"issue":"1","key":"3137_CR11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12944-019-1076-6","volume":"18","author":"HY Wang","year":"2019","unstructured":"Wang HY, Shi WR, Yi X, Zhou YP, Wang ZQ, Sun YX (2019) Assessing the performance of monocyte to high-density lipoprotein ratio for predicting ischemic stroke: insights from a population-based Chinese cohort. Lipids Health Dis 18(1):127. https:\/\/doi.org\/10.1186\/s12944-019-1076-6","journal-title":"Lipids Health Dis"},{"key":"3137_CR12","doi-asserted-by":"publisher","DOI":"10.5551\/jat.51151","author":"H Liu","year":"2020","unstructured":"Liu H, Liu K, Pei L, Gao Y, Zhao L, Sun S, Wu J, Li Y, Fang H, Song B, Xu Y (2020) Monocyte-to-high-density lipoprotein ratio predicts the outcome of acute ischemic stroke. J Atheroscler Thromb. https:\/\/doi.org\/10.5551\/jat.51151","journal-title":"J Atheroscler Thromb"},{"issue":"2","key":"3137_CR13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.pjnns.2017.08.011","volume":"52","author":"A Bolayir","year":"2018","unstructured":"Bolayir A, Gokce SF, Cigdem B, Bolayir HA, Yildiz OK, Bolayir E, Topaktas SA (2018) Monocyte\/high-density lipoprotein ratio predicts the mortality in ischemic stroke patients. Neurol Neurochir Pol 52(2):150\u2013155. https:\/\/doi.org\/10.1016\/j.pjnns.2017.08.011","journal-title":"Neurol Neurochir Pol"},{"key":"3137_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2019.104267","volume":"110","author":"H Haybar","year":"2019","unstructured":"Haybar H, Pezeshki SMS, Saki N (2019) Evaluation of complete blood count parameters in cardiovascular diseases: an early indicator of prognosis? Exp Mol Pathol 110:104267. https:\/\/doi.org\/10.1016\/j.yexmp.2019.104267","journal-title":"Exp Mol Pathol"},{"issue":"8","key":"3137_CR15","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1177\/1076029616663850","volume":"23","author":"A Ar\u0131soy","year":"2017","unstructured":"Ar\u0131soy A, Altunka\u015f F, Karaman K, Karayakal\u0131 M, \u00c7elik A, Ceyhan K, Zorlu \u00c7 (2017) Association of the monocyte to HDL cholesterol ratio with thrombus burden in patients with ST-segment elevation myocardial infarction. Clin Appl Thromb\/Hemost 23(8):992\u2013997. https:\/\/doi.org\/10.1177\/1076029616663850","journal-title":"Clin Appl Thromb\/Hemost"},{"key":"3137_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fendo.2019.00191","volume":"10","author":"JW Chen","year":"2019","unstructured":"Chen JW, Li C, Liu ZH, Shen Y, Ding FH, Shu XY, Zhang RY, Shen WF, Lu L, Wang XQ (2019) The role of monocyte to high-density lipoprotein cholesterol ratio in prediction of carotid intima-media thickness in patients with type 2 diabetes. Front Endocrinol 10:191. https:\/\/doi.org\/10.3389\/fendo.2019.00191","journal-title":"Front Endocrinol"},{"issue":"6","key":"3137_CR17","doi-asserted-by":"publisher","first-page":"901","DOI":"10.7754\/Clin.Lab.2018.171022","volume":"64","author":"G Ya","year":"2018","unstructured":"Ya G, Qiu Z, Tianrong P (2018) Relation of monocyte\/high-density lipoprotein cholesterol ratio with coronary artery disease in type 2 diabetes mellitus. Clin Lab 64(6):901\u2013906. https:\/\/doi.org\/10.7754\/Clin.Lab.2018.171022","journal-title":"Clin Lab"},{"issue":"1","key":"3137_CR18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12944-019-1116-2","volume":"18","author":"TT Wu","year":"2019","unstructured":"Wu TT, Zheng YY, Chen Y, Yu ZX, Ma YT, Xie X (2019) Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention. Lipids Health Dis 18(1):180. https:\/\/doi.org\/10.1186\/s12944-019-1116-2","journal-title":"Lipids Health Dis"},{"issue":"5","key":"3137_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.amjms.2020.01.018","volume":"359","author":"M Sun","year":"2020","unstructured":"Sun M, Zhao D, Zhang Y, Zhai Y, Ye M, Wang X, Zheng L, Wang L (2020) Prognostic utility of monocyte to high-density lipoprotein ratio in patients with acute coronary syndrome: a meta-analysis. Am J Med Sci 359(5):281\u2013286. https:\/\/doi.org\/10.1016\/j.amjms.2020.01.018","journal-title":"Am J Med Sci"},{"issue":"9","key":"3137_CR20","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2217\/bmm-2018-0406","volume":"13","author":"WR Shi","year":"2019","unstructured":"Shi WR, Wang HY, Chen S, Guo XF, Li Z, Sun YX (2019) The impact of monocyte to high-density lipoprotein ratio on reduced renal function: insights from a large population. Biomark Med 13(9):773\u2013783. https:\/\/doi.org\/10.2217\/bmm-2018-0406","journal-title":"Biomark Med"},{"issue":"1","key":"3137_CR21","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1515\/cclm-2016-0005","volume":"55","author":"S Sa\u011f","year":"2017","unstructured":"Sa\u011f S, Y\u0131ld\u0131z A, Aydin Kaderli A, G\u00fcl BC, Bedir \u00d6, Ce\u011filli E, \u00d6zdemir B, Can FE, Ayd\u0131nlar A (2017) Association of monocyte to HDL cholesterol level with contrast induced nephropathy in STEMI patients treated with primary PCI. Clin Chem Lab Med 55(1):132\u2013138. https:\/\/doi.org\/10.1515\/cclm-2016-0005","journal-title":"Clin Chem Lab Med"},{"issue":"10","key":"3137_CR22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1177\/0003319718760916","volume":"69","author":"T Ulus","year":"2018","unstructured":"Ulus T, Isgandarov K, Yilmaz AS, Uysal S, Vasi I, Dural M, Mutlu F (2018) Monocyte to high-density lipoprotein ratio predicts contrast-induced nephropathy in patients with acute coronary syndrome. Angiology 69(10):909\u2013916. https:\/\/doi.org\/10.1177\/0003319718760916","journal-title":"Angiology"},{"issue":"9","key":"3137_CR23","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"issue":"3","key":"3137_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s40620-017-0393-y","volume":"31","author":"V Cernaro","year":"2018","unstructured":"Cernaro V, Lucisano S, Canale V, Bruzzese A, Caccamo D, Costantino G, Buemi M, Santoro D (2018) Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study. J Nephrol 31(3):429\u2013433. https:\/\/doi.org\/10.1007\/s40620-017-0393-y","journal-title":"J Nephrol"},{"key":"3137_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/kisup.2012.77","volume":"3","author":"KDIGO","year":"2012","unstructured":"KDIGO (2012) Clinical practice guideline for the evaluation and management of chronic kidney disease (2013). Kidney Int Suppl 3:5\u201314. https:\/\/doi.org\/10.1038\/kisup.2012.77","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"3137_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.31083\/j.rcm.2019.04.548","volume":"20","author":"M Provenzano","year":"2019","unstructured":"Provenzano M, Coppolino G, Faga T, Garofalo C, Serra R, Andreucci M (2019) Epidemiology of cardiovascular risk in chronic kidney disease patients: the real silent killer. Rev Cardiovasc Med 20(4):209\u2013220. https:\/\/doi.org\/10.31083\/j.rcm.2019.04.548","journal-title":"Rev Cardiovasc Med"},{"key":"3137_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/toxins10050202","author":"H Fujii","year":"2018","unstructured":"Fujii H, Goto S, Fukagawa M (2018) Role of uremic toxins for kidney, cardiovascular, and bone dysfunction. Toxins. https:\/\/doi.org\/10.3390\/toxins10050202","journal-title":"Toxins"},{"key":"3137_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.toxlet.2019.03.002","volume":"308","author":"F Savira","year":"2019","unstructured":"Savira F, Magaye R, Hua Y, Liew D, Kaye D, Marwick T, Wang BH (2019) Molecular mechanisms of protein-bound uremic toxin-mediated cardiac, renal and vascular effects: underpinning intracellular targets for cardiorenal syndrome therapy. Toxicol Lett 308:34\u201349. https:\/\/doi.org\/10.1016\/j.toxlet.2019.03.002","journal-title":"Toxicol Lett"},{"issue":"7","key":"3137_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132589","volume":"10","author":"CJ Lin","year":"2015","unstructured":"Lin CJ, Wu V, Wu PC, Wu CJ (2015) Meta-analysis of the associations of p-cresyl sulfate (PCS) and indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failure. PLoS ONE 10(7):e0132589. https:\/\/doi.org\/10.1371\/journal.pone.0132589","journal-title":"PLoS ONE"},{"key":"3137_CR30","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.3389\/fphys.2018.01623","volume":"9","author":"M Karbowska","year":"2018","unstructured":"Karbowska M, Kaminski TW, Znorko B, Domaniewski T, Misztal T, Rusak T, Pryczynicz A, Guzinska-Ustymowicz K, Pawlak K, Pawlak D (2018) Indoxyl sulfate promotes arterial thrombosis in rat model via increased levels of complex TF\/VII, PAI-1, platelet activation as well as decreased contents of SIRT1 and SIRT3. Front Physiol 9:1623","journal-title":"Front Physiol"},{"issue":"1","key":"3137_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12882-017-0457-1","volume":"18","author":"TW Kami\u0144ski","year":"2017","unstructured":"Kami\u0144ski TW, Pawlak K, Karbowska M, My\u015bliwiec M, Pawlak D (2017) Indoxyl sulfate\u2014the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease. BMC Nephrol 18(1):35","journal-title":"BMC Nephrol"},{"issue":"5","key":"3137_CR32","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1053\/j.ajkd.2009.06.019","volume":"54","author":"JF Winchester","year":"2009","unstructured":"Winchester JF, Hostetter TH, Meyer TW (2009) p-Cresol sulfate: further understanding of its cardiovascular disease potential in CKD. Am J Kidney Dis 54(5):792\u2013794","journal-title":"Am J Kidney Dis"},{"key":"3137_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/toxins10070300","author":"E Castillo-Rodriguez","year":"2018","unstructured":"Castillo-Rodriguez E, Fernandez-Prado R, Esteras R, Perez-Gomez MV, Gracia-Iguacel C, Fernandez-Fernandez B, Kanbay M, Tejedor A, Lazaro A, Ruiz-Ortega M, Gonzalez-Parra E, Sanz AB, Ortiz A, Sanchez-Ni\u00f1o MD (2018) Impact of altered intestinal microbiota on chronic kidney disease progression. Toxins. https:\/\/doi.org\/10.3390\/toxins10070300","journal-title":"Toxins"},{"issue":"23","key":"3137_CR34","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/j.jchromb.2011.06.014","volume":"879","author":"R Calaf","year":"2011","unstructured":"Calaf R, Cerini C, G\u00e9nov\u00e9sio C, Verhaeghe P, Jourde-Chiche N, Berg\u00e9-Lefranc D, Gondouin B, Dou L, Morange S, Argil\u00e9s A, Rathelot P, Dignat-George F, Brunet P, Charpiot P (2011) Determination of uremic solutes in biological fluids of chronic kidney disease patients by HPLC assay. J Chromatogr B Anal Technol Biomed Life Sci 879(23):2281\u20132286. https:\/\/doi.org\/10.1016\/j.jchromb.2011.06.014","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"issue":"6","key":"3137_CR35","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.kint.2020.01.028","volume":"97","author":"T Gryp","year":"2020","unstructured":"Gryp T, De Paepe K, Vanholder R, Kerckhof FM, Van Biesen W, Van de Wiele T, Verbeke F, Speeckaert M, Joossens M, Couttenye MM, Vaneechoutte M, Glorieux G (2020) Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease. Kidney Int 97(6):1230\u20131242. https:\/\/doi.org\/10.1016\/j.kint.2020.01.028","journal-title":"Kidney Int"},{"issue":"3","key":"3137_CR36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/circulationaha.112.118174","volume":"127","author":"VC Chitalia","year":"2013","unstructured":"Chitalia VC, Shivanna S, Martorell J, Balcells M, Bosch I, Kolandaivelu K, Edelman ER (2013) Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor. Circulation 127(3):365\u2013376. https:\/\/doi.org\/10.1161\/circulationaha.112.118174","journal-title":"Circulation"},{"key":"3137_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/toxins10100412","author":"T Addi","year":"2018","unstructured":"Addi T, Dou L, Burtey S (2018) Tryptophan-derived uremic toxins and thrombosis in chronic kidney disease. Toxins. https:\/\/doi.org\/10.3390\/toxins10100412","journal-title":"Toxins"},{"issue":"15","key":"3137_CR38","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1021\/acs.biochem.8b01305","volume":"58","author":"JS Brito","year":"2019","unstructured":"Brito JS, Borges NA, Anjos JSD, Nakao LS, Stockler-Pinto MB, Paiva BR, Cardoso-Weide LC, Cardozo L, Mafra D (2019) Aryl hydrocarbon receptor and uremic toxins from the gut microbiota in chronic kidney disease patients: is there a relationship between them? Biochemistry 58(15):2054\u20132060. https:\/\/doi.org\/10.1021\/acs.biochem.8b01305","journal-title":"Biochemistry"},{"issue":"10","key":"3137_CR39","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.bbadis.2013.05.002","volume":"1832","author":"AC Dankers","year":"2013","unstructured":"Dankers AC, Mutsaers HA, Dijkman HB, van den Heuvel LP, Hoenderop JG, Sweep FC, Russel FG, Masereeuw R (2013) Hyperuricemia influences tryptophan metabolism via inhibition of multidrug resistance protein 4 (MRP4) and breast cancer resistance protein (BCRP). Biochim Biophys Acta 1832(10):1715\u20131722. https:\/\/doi.org\/10.1016\/j.bbadis.2013.05.002","journal-title":"Biochim Biophys Acta"},{"issue":"23\u201324","key":"3137_CR40","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1016\/j.cca.2011.07.031","volume":"412","author":"Y Liu","year":"2011","unstructured":"Liu Y, Sun X, Di D, Quan J, Zhang J, Yang X (2011) A metabolic profiling analysis of symptomatic gout in human serum and urine using high performance liquid chromatography-diode array detector technique. Clin Chim Acta 412(23\u201324):2132\u20132140. https:\/\/doi.org\/10.1016\/j.cca.2011.07.031","journal-title":"Clin Chim Acta"},{"issue":"5","key":"3137_CR41","doi-asserted-by":"publisher","first-page":"359","DOI":"10.4103\/ijn.IJN_71_17","volume":"27","author":"S Gouroju","year":"2017","unstructured":"Gouroju S, Rao PVLNS, Bitla AR, Vinapamula KS, Manohar SM, Vishnubhotla S (2017) Role of gut-derived uremic toxins on oxidative stress and inflammation in patients with chronic kidney disease. Indian J Nephrol 27(5):359\u2013364. https:\/\/doi.org\/10.4103\/ijn.IJN_71_17","journal-title":"Indian J Nephrol"},{"issue":"1","key":"3137_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1177\/0003319717704748","volume":"69","author":"N Acikgoz","year":"2018","unstructured":"Acikgoz N, Kurto\u011flu E, Yagmur J, Kapicioglu Y, Cansel M, Ermis N (2018) Elevated monocyte to high-density lipoprotein cholesterol ratio and endothelial dysfunction in Beh\u00e7et disease. Angiology 69(1):65\u201370. https:\/\/doi.org\/10.1177\/0003319717704748","journal-title":"Angiology"},{"issue":"5","key":"3137_CR43","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1177\/1076029615594002","volume":"22","author":"U Canpolat","year":"2016","unstructured":"Canpolat U, \u00c7etin EH, Cetin S, Aydin S, Akboga MK, Yayla C, Turak O, Aras D, Aydogdu S (2016) Association of monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation. Clin Appl Thromb\/Hemost 22(5):476\u2013482. https:\/\/doi.org\/10.1177\/1076029615594002","journal-title":"Clin Appl Thromb\/Hemost"},{"issue":"1","key":"3137_CR44","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12872-020-01670-3","volume":"20","author":"SA Chen","year":"2020","unstructured":"Chen SA, Zhang MM, Zheng M, Liu F, Sun L, Bao ZY, Chen FK, Li HX, Gu X (2020) The preablation monocyte\/ high density lipoprotein ratio predicts the late recurrence of paroxysmal atrial fibrillation after radiofrequency ablation. BMC Cardiovasc Disord 20(1):401. https:\/\/doi.org\/10.1186\/s12872-020-01670-3","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"3137_CR45","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3892\/ijmm.2020.4644","volume":"46","author":"S Selvaggio","year":"2020","unstructured":"Selvaggio S, Abate A, Brugaletta G, Musso C, Di Guardo M, Di Guardo C, Vicari ESD, Romano M, Luca S, Signorelli SS (2020) Platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio and monocyte-to-HDL cholesterol ratio as markers of peripheral artery disease in elderly patients. Int J Mol Med 46(3):1210\u20131216. https:\/\/doi.org\/10.3892\/ijmm.2020.4644","journal-title":"Int J Mol Med"},{"issue":"1","key":"3137_CR46","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12944-020-01242-6","volume":"19","author":"DLE Villanueva","year":"2020","unstructured":"Villanueva DLE, Tiongson MD, Ramos JD, Llanes EJ (2020) Monocyte to High-Density Lipoprotein Ratio (MHR) as a predictor of mortality and Major Adverse Cardiovascular Events (MACE) among ST Elevation Myocardial Infarction (STEMI) patients undergoing primary percutaneous coronary intervention: a meta-analysis. Lipids Health Dis 19(1):55. https:\/\/doi.org\/10.1186\/s12944-020-01242-6","journal-title":"Lipids Health Dis"},{"issue":"8","key":"3137_CR47","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s11255-014-0730-1","volume":"46","author":"M Kanbay","year":"2014","unstructured":"Kanbay M, Solak Y, Unal HU, Kurt YG, Gok M, Cetinkaya H, Karaman M, Oguz Y, Eyileten T, Vural A, Covic A, Goldsmith D, Turak O, Yilmaz MI (2014) Monocyte count\/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol 46(8):1619\u20131625. https:\/\/doi.org\/10.1007\/s11255-014-0730-1","journal-title":"Int Urol Nephrol"},{"issue":"7","key":"3137_CR48","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.numecd.2020.03.011","volume":"30","author":"X Zhan","year":"2020","unstructured":"Zhan X, Pan D, Wei X, Wen D, Yan C, Xiao J (2020) Monocyte to high-density lipoprotein ratio and cardiovascular events in patients on peritoneal dialysis. Nutr Metab Cardiovasc Dis 30(7):1130\u20131136. https:\/\/doi.org\/10.1016\/j.numecd.2020.03.011","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"3137_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149276","volume":"11","author":"C Barisione","year":"2016","unstructured":"Barisione C, Garibaldi S, Furfaro AL, Nitti M, Palmieri D, Passalacqua M, Garuti A, Verzola D, Parodi A, Ameri P, Altieri P, Fabbi P, Ferrar PF, Brunelli C, Arsenescu V, Balbi M, Palombo D, Ghigliotti G (2016) Moderate increase of indoxyl sulfate promotes monocyte transition into profibrotic macrophages. PLoS ONE 11(2):e0149276. https:\/\/doi.org\/10.1371\/journal.pone.0149276","journal-title":"PLoS ONE"},{"issue":"4","key":"3137_CR50","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1385\/ct:4:4:363","volume":"4","author":"CF Vogel","year":"2004","unstructured":"Vogel CF, Sciullo E, Matsumura F (2004) Activation of inflammatory mediators and potential role of ah-receptor ligands in foam cell formation. Cardiovasc Toxicol 4(4):363\u2013373. https:\/\/doi.org\/10.1385\/ct:4:4:363","journal-title":"Cardiovasc Toxicol"},{"issue":"1\u20132","key":"3137_CR51","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.lfs.2012.06.002","volume":"91","author":"E Naem","year":"2012","unstructured":"Naem E, Alcalde R, Gladysz M, Mesliniene S, Jaimungal S, Sheikh-Ali M, Haas MJ, Wong NC, Mooradian AD (2012) Inhibition of apolipoprotein A-I gene by the aryl hydrocarbon receptor: a potential mechanism for smoking-associated hypoalphalipoproteinemia. Life Sci 91(1\u20132):64\u201369. https:\/\/doi.org\/10.1016\/j.lfs.2012.06.002","journal-title":"Life Sci"},{"issue":"4","key":"3137_CR52","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","volume":"8","author":"M Navab","year":"2011","unstructured":"Navab M, Reddy ST, Van Lenten BJ, Fogelman AM (2011) HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol 8(4):222\u2013232. https:\/\/doi.org\/10.1038\/nrcardio.2010.222","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"3137_CR53","first-page":"28","volume":"50","author":"G Galli","year":"1998","unstructured":"Galli G, Panzetta G (1998) Acetate free biofiltration (AFB): from theory to clinical results. Clin Nephrol 50(1):28\u201337","journal-title":"Clin Nephrol"},{"issue":"5","key":"3137_CR54","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/1744-9987.12684","volume":"22","author":"V Cernaro","year":"2018","unstructured":"Cernaro V, Tripepi G, Visconti L, Lacquaniti A, Montalto G, Romeo A, Cimadoro D, Costantino G, Torre F, Santoro D, Buemi M (2018) Convective dialysis reduces mortality risk: results from a large observational, population-based analysis. Ther Apher Dial 22(5):457\u2013468. https:\/\/doi.org\/10.1111\/1744-9987.12684","journal-title":"Ther Apher Dial"},{"key":"3137_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21062031","author":"S Liabeuf","year":"2020","unstructured":"Liabeuf S, Laville SM, Glorieux G, Cheddani L, Brazier F, Titeca Beauport D, Valholder R, Choukroun G, Massy ZA (2020) Difference in profiles of the gut-derived tryptophan metabolite indole acetic acid between transplanted and non-transplanted patients with chronic kidney disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21062031","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3137_CR56","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/toxins12040234","volume":"12","author":"MK van Gelder","year":"2020","unstructured":"van Gelder MK, Middel IR, Vernooij RWM, Bots ML, Verhaar MC, Masereeuw R, Grooteman MP, Nub\u00e9 MJ, van den Dorpel MA, Blankestijn PJ, Rookmaaker MB, Gerritsen KGF (2020) Protein-bound uremic toxins in hemodialysis patients relate to residual kidney function, are not influenced by convective transport, and do not relate to outcome. Toxins (Basel) 12(4):234","journal-title":"Toxins (Basel)"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-022-03137-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-022-03137-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-022-03137-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T06:36:19Z","timestamp":1660199779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-022-03137-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":56,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["3137"],"URL":"https:\/\/doi.org\/10.1007\/s11255-022-03137-0","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,11]]},"assertion":[{"value":"20 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all the authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed according to the ethical standards of the 1964 Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all recruited patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All the authors approved the submission of the article for publication in the Journal.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}